Las Vegas, NV -- (SBWIRE) -- 09/25/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: BioScrip Inc (NASDAQ:BIOS), Greenway Medical Technologies, Inc.(NYSE:GWAY), Alpha Natural Resources, Inc.(NYSE:ANR), Novavax, Inc.(NASDAQ:NVAX)
BioScrip Inc (NASDAQ:BIOS) managed to keep its fall at -18.64% on below -normal volume of 9.49M shares. The stock settled at $8.47 after floating in a range of $3.38 to $10.58. Its latest price has reached market capitalization of $574.09million. Its 52-week range has been $8.38 to $17.62. BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit management (PBM) services in the United States. It operates in three segments: Infusion Services, Home Health Services, and PBM Services.
Has BIOS Found The Bottom and Ready To Move Up? Find Out Here
Greenway Medical Technologies, Inc. (NYSE:GWAY) traded up on a volume of 9.04 million, higher than its standard daily volume. Shares have gained 19.09% to $20.40. Over the last twelve months, the stock has gained 27.98% and faced a worst price of $10.30. Greenway Medical Technologies, Inc. develops, markets, and sells integrated information technology solutions and managed business services to ambulatory healthcare providers in the United States.
For How Long GWAY’s Gloss will Attract Investors? Find out via this report
Alpha Natural Resources, Inc. (NYSE:ANR) settled -1.59% lower at $6.17 on below -normal volume of 7.65M shares during the last trading day. The stock has its 12-month high at $10.74 and 52-week low price was $4.78. It traded in a range of $6.12 to $6.30 during the last trading day. Alpha Natural Resources, Inc., together with its subsidiaries, engages in extracting, processing, and marketing steam and metallurgical coal in Virginia, West Virginia, Kentucky, Pennsylvania, and Wyoming.
Will ANR Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Novavax, Inc. (NASDAQ:NVAX) was up on high volume, trading at a volume of 7.46M versus its average daily volume of 3.54 million shares. At $3.21, the stock has attained market capitalization of 490.23 million. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases.
Will NVAX Continue To Move Higher? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)